This document discusses the treatment of metabolic acidosis in chronic kidney disease (CKD). It notes that metabolic acidosis is common in advanced CKD, occurring in 30-50% of individuals with eGFR below 30 ml/min/1.73m2. For chronic metabolic acidosis, the recommended approach is oral bicarbonate supplementation. For acute severe metabolic acidosis with a pH below 7.2, hemodialysis or intravenous bicarbonate to raise serum bicarbonate levels above 8 and pH above 7.2 is recommended. The document outlines potential side effects of bicarbonate therapy including increased volume, sodium levels, and intracellular acidosis.